Akanda Corp. (AKAN) vs XORTX Therapeutics Inc. (XRTX)
A side-by-side comparison of Akanda Corp. and XORTX Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AKAN
Akanda Corp.
$1.89HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
XRTX
XORTX Therapeutics Inc.
$1.73HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AKAN vs XRTX
growth of $100 · dividends reinvested · last 5yAKAN -100.0% (-91.8%/yr)XRTX -96.9% (-50.1%/yr)XRTX compounded faster over this window
Log scale — wide-divergence pair
AKAN XRTX
AKAN vs XRTX: by the numbers
- •XRTX is the larger company ($481786 vs $61172 market cap).
- •Both run net losses; XRTX's is the smaller (0.00% vs -17690.19% net margin).
Metrics side by side
Valuation
| Metric | AKAN | XRTX |
|---|---|---|
| P/B ratio | N/A | 0.09 |
Profitability
| Metric | AKAN | XRTX |
|---|---|---|
| Gross margin | -60.46% | 0.00% |
| Operating margin | -1930.99% | 0.00% |
| Net margin | -17690.19% | 0.00% |
| ROE | N/A | -68.17% |
| ROIC | -242.09% | -71.43% |
Growth (annualized)
| Metric | AKAN | XRTX |
|---|---|---|
| Revenue CAGR (5Y) | 162.75% | N/A |
| Total return CAGR (5Y) | N/A | -63.52% |
Go deeper
Dig into the metrics
Akanda ROEXORTX Therapeutics ROEAkanda operating marginXORTX Therapeutics operating marginAkanda revenue growthXORTX Therapeutics revenue growthAkanda free cash flowXORTX Therapeutics free cash flow
Akanda & XORTX Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.